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49SVZ Response to Brain Injuryincreased numbers of GFAP+/EGFR+ stem cells via non-proliferative means—potentially through the dedifferentiation of
progenitor cells. EGFR+ progenitors from injured brains only were competent to revert to a stem cell state following brief exposure
to growth factors. Thus, our results demonstrate previously unknown changes in lineage relationships that differ from conventional
models and likely reflect an adaptive response of the SVZ to maintain endogenous brain repair after TBI.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
While increased proliferation and an expansion in the size of
the SVZ are well-known phenomena after brain injury, the
cellular underpinnings of this effect are not well understood.
In addition, although injury-induced neurogenesis has been
detected in the adult brain from the subventricular zone
(SVZ) and hippocampus (Gould and Tanapat, 1997; Yagita et
al., 2001; Parent et al., 2002; Thored et al., 2006) and in
non-neurogenic regions (Tonchev et al., 2003; Yamamoto et
al., 2001; Magavi et al., 2000) the regenerative capacity
of the brain remains low (Arvidsson et al., 2002). Thus,
therapeutic intervention aimed at certain cell populations
or within specific time-frames post-injury are needed
to enhance and support the endogenous neurogenic
response.
Under uninjured conditions, stem cells in the SVZ are a
relatively quiescent population of cells (Morshead et al.,
1994; Doetsch et al., 1999a,1999b; Garcia et al., 2004;
Imura et al., 2003), while transit-amplifying progenitors
(Doetsch et al., 2002; Cesetti et al., 2009; Kim et al., 2009)
and some neuroblasts (Brown et al., 2003) are populations of
actively proliferating cells. According to the current models
of SVZ lineage progression, the development from slowly-
dividing GFAP+ stem cell to migrating neuroblast occurs
following activation and co-expression of epidermal growth
factor receptor (EGFR). These GFAP+/EGFR+ stem cells give
rise to GFAP−/EGFR+ transit amplifying cells, which rapidly
divide to generate DCX+ neuroblasts and continue to divide as
they migrate toward the olfactory bulb where they become
functional interneurons (Pastrana et al., 2009). Although
studies utilizing the deletion of specific SVZ cell populations
demonstrate this specific pattern of cellular hierarchy in
the uninjured brain, it is unknown whether injury-induced
SVZ cell proliferation involves changes to this normal
lineage progression, and which specific cell phenotypes
are most affected. Resolution of this post-injury biology is
important for understanding the ability of SVZ-derived stem
and progenitor cells to contribute to the brain's natural
repair process.
To address this gap in knowledge we examined the
cellular changes within the SVZ after traumatic brain injury
(TBI) in a murine model. We identified a significant non-
proliferative increase in neural stem cells and a divergent
response to injury by different transit amplifying progenitor
populations. Our data also suggest that injury-induced
signaling through the EGF receptor may result in the
dedifferentiation of a progenitor population back into a
stem cell state. Thus, these alterations to cell lineage
relationships in the SVZ are likely to be important regulators
of the enhanced proliferation and neurogenesis known to
be induced by brain injury. Therefore, EGFR-signaling inparticular may be an important therapeutic target for
optimizing the post-injury cellular response to promote
functional recovery.
Materials and methods
Animals
C57Bl/6 mice purchased from Charles River Laboratory were
housed under NIH guidelines and all experiments were
conducted in accordance with the University of California,
Los Angeles, (UCLA) Chancellor's Animal Research Commit-
tee and the Public Health Service Policy on Humane Care and
Use of Laboratory Animals. Transgenic mice expressing the
herpes simplex virus-thymidine kinase from the mouse glial
fibrillary acid protein promoter (GFAP-TK mice) were
supplied by the Sofroniew Lab at UCLA. The pattern and
regulation of transgene-derived HSV-TK expression is similar
to that of endogenous GFAP, to the extent that 100% of TK
cells co-localize with GFAP in both uninjured mice (Garcia et
al., 2004) or in stab wound-injured mice (Bush et al., 1998).
Adult male mice at least 3 months of age were used in all
experiments.
5-Chloro-2′-deoxyuridine (CldU) labeling
To label cells that were actively proliferating on the day
of euthanasia (1, 3, or 7 days post-injury), 42.5 mg/kg
5-chloro-2′-deoxyuridine (CldU) was administered intraper-
itoneally every 2 h over the course of 8 h (4 injections total)
and mice were euthanized 2 h after the last injection. To
identify GFAP-TK+ cells that arise from actively dividing
cells after injury, animals were injected with CldU immedi-
ately after injury and every 2 h thereafter for a total of 4
injections and animals were euthanized 3 days following
injury.
5-Iodo-2′-deoxyuridine (IdU) labeling
For label-retaining experiments, intraperitoneal (IP) injec-
tions of IdU (Sigma I7125; 57.5 mg/kg) were administered to
adult mice, once daily for three weeks to label all dividing
cells, even the slowly dividing stem cells. Naïve animals
were euthanized immediately or after a label washout
period of 10 days in which no injections were given. Over
this 10 day wash out period the IdU label intensity within
proliferating cells will diminish by half with every division,
so that fast dividing cells become dim or undetectable
and quiescent cells remain brightly labeled (see Results).
Animals in the injury group received a TBI 7 days after
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injury (corresponding to a total 10-day washout). IdU was
prepared at a concentration of 3.2 mg/ml in .08 N NaOH in
sterile saline and pH was neutralized using concentrated
HCl.
Controlled cortical impact (CCI) injury
Mice were anesthetized with isoflurane and positioned
within a mouse stereotaxic frame. Following a longitudinal
skin incision, a 6 mmdiameter craniotomywasmade centered
at 3 mm posterior to bregma and 3 mm lateral to the midline.
Cortical injury was performed with a flat, 3 mm diameter
metal tip attached to the CCI device, at 15 psi and to a depth
of 0.6 mm below the dura. The skull flap was replaced and
glued in place with Loctite Ultra Gel-Control super glue before
suturing the wound closed (see Myer et al., 2006).
Tissue fixation, brain sectioning
& immunohistochemistry
Mice were deeply anesthetized with pentobarbital (50 mg/kg)
and perfused/fixed with .9% PBS followed by 4% paraformalde-
hyde. 40 μm coronal sections were cut and standard, multi-
label fluorescent immunohistochemistry was performed using
the following antibodies: rat anti-BrdU/CldU (1:250, Accurate
Chemicals, Westbury, NY, Clone BU 1/75), mouse anti-BrdU/
IdU (1:250, BD, Franklin Lakes, NJ, Clone B44), rabbit anti-GFAP
(1:2000, Dako, Carpinteria, CA), rabbit anti-TK (from Dr.
Michael Sofroniew), sheep anti-EGFR (1:5000, Capralogics,
Hardwick, MA), mouse anti-Mash1 (1:250, BD, Franklin Lakes,
NJ), rabbit anti-DCX (1:500, Abcam, Cambridge UK), rabbit
anti-Iba1 (1:250, Wako, Richmond, VA). Alexafluorophore-
conjugated secondary probes (Molecular Probes, Carlsbad, CA)
were used. For CldU and IdU staining, antigen-retrieval was
performed by first incubating sections in 10 mM sodium citrate
at N95 °C for 15 min followed by incubation in 2N HCl at 37 °C
for 25 min.
Contusion analysis
Six sections (480 μm apart) were Nissl-stained, digitally
scanned and analyzed for contusion volume analysis using
previous published methods (Chen et al., 2003). Single,
representative sections at bregma +0.48 from 12 mice at
7 days after injury were scanned on a flatbed scanner and
digitally co-registered by affine transformations (Jenkinson
and Smith, 2001). Lesioned areas were thenmanually outlined
before images were merged by summation, rescaled and
colorized to represent the degree of lesion overlap.
Microscopy
Stereological analysis was performed to quantify the following
populations of cells: CldU, GFAP-TK, EGFR, CldU/Mash1,
CldU/GFAP-TK and CldU/EGFR. The estimated total number
of single- and double-labeled cells was determined by
epifluorescence microscopy using unbiased stereology cell
counts with the optical fractionator method, as implemented
by StereoInvestigator software (MicroBrightfield, Williston,VT, USA) in four 40 μm sections that were 240 μmapart within
the SVZ region beginning rostrally at the genu of the corpus
callosum. Counting regions were grossly defined under DAPI
nuclear stain immunofluorescence by contouring an area
extending from the junction of the lateral ventricle and
dorsolateral SVZ to 100 μm medially, 100 μm ventrally and
175 μm laterally. Labeled cells were counted at 100× total
magnification using a grid size of 35 × 35 μm with a sampling
box of 15 × 15 μm and were reported as estimated total cell
populations.
Accurate stereological quantification was not possible for
all cell populations: the abundance of DCX+ cells throughout
the SVZ and staining within their processes did not allow for
unambiguous identification of double-labeled cells. Addi-
tionally, limitations in available filter sets did not allow for
stereological analysis of triple-labeled populations (CldU/
GFAP-TK/EGFR). Therefore, confocal microscopy was used
for identification and semi-quantification of the CldU/DCX
population and of cells triple-labeled for CldU/GFAP-TK/
EGFR. Three 75 μm2 fields-of-view (FOVs) were analyzed
for cell numbers within four sections (12 FOVs total) as
described for use with stereology. FOVs were chosen to
include the entire cell-dense areas directly lateral to,
and continuing dorsolaterally from the lateral ventricle/
dorsolateral SVZ junction. Cell numbers were expressed
as percentages of total cells analyzed for each brain.
Semi-quantitative data for total cell numbers of double-
and triple-labeled populations for comparative purposes in
Supplemental Table 1 were derived from the percentages of
total cell populations obtained with confocal microscopy
Z-stack analysis and the corresponding total stereological
counts of CldU+, EGFR+ and GFAP+ cells that were obtained
from the same brains. Statistical analysis was performed on
the original percent-calculated data.
The same tissue sections (n = 4/brain) were used to
measure dorsolateral SVZ thickness, which was accomplished
using DAPI-illuminated sections by measuring the distance
from the ventricle to the edge of the cell dense region directly
lateral to the ventricle/dorsolateral SVZ junction at 40×
magnification. Eachmeasurementwas repeated 3 timeswithin
each section and for 4 sections/brain.Flow cytometry
Dissected SVZ tissue was enzymatically digested using Accumax
(Sigma-Aldrich, USA) and mechanically triturated using a fire-
polished Pasteur pipette into a single cell suspension. The cells
were immunostained with an EGFR antibody conjugated with
FITC secondary antibody (Cell Signaling Technology, Danvers,
MA) in Hibernate media (BrainBits, Springfield, IL) with 4%
normal goat serum. The cells were analyzed using a FACSDiVa
cell sorter (BD Biosciences, San Jose, CA) flow cytometer and
FlowJo analysis software (Treestar, Ashland, OR) for the
collection of live EGFR+ cells. Sort gates were set by side
and forward scatter to eliminate dead and aggregated cells and
with negative control cell samples. For assessing intracellular
GFAP expression the EGFR+ cells were placed in culture media
with or without 20 ng/ml EGF for 4 h. After the incubation
period the cells were fixed and permeabilized using the Fix &
PERM kit (Invitrogen, Grand Island, NY) and immunostaining
with polyclonal GFAP (Invitrogen) and anti-rabbit PerCP
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cell sorter as described above.
Clonal neurosphere-forming assay
The EGFR+ sorted cells were cultured at clonal density as
described previously (Le Belle et al., 2011). Briefly, the cells
were seeded into 96-well plates at 100 cells per ml of
media. Clonally-derived neurospheres were counted and
their diameters measured using a brightfield illumination
and image analysis software (MCID, Imaging Research, St.
Catharines, ON, Canada). A minimum diameter cutoff of
40 μm was used in defining a neurosphere. Intact clonal
neurospheres were also plated down on poly-D-lysine-
(100 μg/ml; Invitrogen) and laminin-coated (10 μg/ml;
Invitrogen) glass coverslips in mitogen-free media for
7 days to differentiate for multipotency analysis.
Immunocytochemistry
Differentiated cells were fixed in 4% paraformaldehyde
in PBS for 20 min. Immunostaining was carried out using
standard protocols. Primary antibodies and dilutions were as
follows: β-tubulin type III monoclonal (TuJ1, 1:500; Sigma,
St. Louis, MO), GFAP polyclonal (1:1000; DAKO, Carpinteria,
CA), O4 (1:50 hybridoma supernatant; gift from De Vellis
lab). Cells were then reacted with appropriate secondary
antibodies (Alexa 488 or 568, Invitrogen; 1:2000) and Hoechst
nuclear stain (1:5000).
Label-retaining cell intensity analysis
Animals were given daily IdU injections for 3 weeks to label all
dividing SVZ cells, including the slowly dividing stem cell
population. This was followed by a 10-day washout period
during which time all dividing cells would dilute the IdU label
and quiescent cells can be identified. TBI was performed on
day 3 of the washout period. Perfusion fixation was carried out
on day 10 of the washout period. All brain sections for analysis
were immunostained for IdU and GFAP at the same time using
the same antibody solutions and sections were photographed
at the same exposure time using epi-fluorescence at 40×
magnification. Raw imageswere not adjusted for brightness or
contrast. All imageswere photographedwith an exposure time
of 800 ms, using an RS Photometrics CoolSNAP camera and
Image Pro Plus software (Media Cybernetics, Inc., Bethesda,
MD, USA). After images were collected, cells were visualized
in Image J (Rasband, 2008) and regions of interest were drawn
manually around only whole cells that were completely in
focus. Cell intensity values were measured for each cell of
interest (found within 2 fields of view (FOV)/section over 4
sections). FOVs were chosen to include the entire cell-dense
areas directly lateral to, and continuing dorsolaterally from
the ventricle/dorsolateral SVZ junction. Intensity values for
cells within an individual image were corrected by subtracting
the average intensity value of the background. IdU+ cells
analyzed within the SVZ of an individual animal were
segregated into groups based on label intensity where the
most intense label retention represents the cells that did not
divide during the 10-day washout period. The non-dividing
group of label-retaining cells (LRCs) corresponded to thetop 40% intensity of IdU label (~6% of the total LRC
cell population). The quiescence of this high intensity LRC
population was confirmed by lack of the proliferation marker
CldU, given immediately before perfusion fixation. The
remaining, dimmer IdU cell populations that were not true
LRCs were indeed shown to be proliferative by the CldU
marker and were therefore excluded from the LRC analysis.
The population of high-intensity label-retaining cells was then
evaluated for co-expression of GFAP and the number of GFAP+
LRCS was quantified stereologically.
Statistical analysis
For each quantitative analysis including thickness measure-
ment, cell counting, clonal neurosphere analysis and contusion
volume analysis, the mean ± standard errors of at least three
independent experiments were calculated and statistical
significance tests (t-test or one-way ANOVA with Tukey's HSD
post hoc) were performed using the “R” statistical package (R
Development Core Team, 2008). Statistical significance (α)
was set at P b 0.05 for all comparisons.
Results
TBI increases the size of the SVZ and the number of
proliferating SVZ cells
We confirmed that SVZ proliferation and expansion occur in the
moderate controlled cortical impact injury model of traumatic
brain injury (TBI) used in these studies and that it did not
directly involve injury to the SVZ itself (Fig. 1A). Using an 8-hour
exposure to the thymidine analog 5-chloro-2′-deoxyuridine
(CldU) on the day of euthanasia post-injury, we found that the
number of actively dividing SVZ cells was significantly increased
relative to uninjured (naïve) controls in the dorsolateral SVZ at
1, 3 and 7 days following TBI (P b 0.05, Figs. 1B–E). Accord-
ingly, we observed an approximately 25% expansion in the
thickness of the SVZ by three days post-injury (p b 0.05,
compared to controls Fig. 1F). While it is known that there is a
substantial inflammatory response within the injured cortex
after TBI, consisting of dividing glial and inflammatory cells
(Chen et al., 2003), it was not known whether this would occur
within the SVZ and contribute to the SVZ expansion after injury.
We found almost no change in the proliferation of IBA1+
microglia in the SVZ after injury compared to naïve (Figs. 1G–I).
Injury does not induce proliferation of
DCX+ neuroblasts within the SVZ
In order to determine which cells are directly responsible for
the increased numbers of actively dividing cells in the SVZ
after injury, we quantified the amount of cell division in a
number of different cell phenotypes at 1, 3, and 7 days after
injury (Fig. 1B). We first looked at DCX+ neuroblasts for their
potential contribution to the post-injury increases in SVZ
proliferation. We found that 35% of the actively dividing
(CldU+) cells within the uninjured SVZ expressed DCX and
this percentage was unchanged at 1-day post-injury (Figs.
2A, B). However, the proliferation of the DCX population
significantly decreased to 19% and 17% by 3 and 7 days
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could result from less DCX+ cell proliferation or from an
increase in the migration of these cells away from the SVZ.
In fact, increased total numbers of DCX+ cells were detected
in the corpus callosum underlying the cortical injury and in
the cortex itself (data not shown). Regardless of the cause of
the decrease in dividing DCX+ cells in the SVZ, this data
demonstrates that DCX+ cells do not significantly contribute
to the proliferative expansion of the SVZ after injury.Figure 1 Brain injury increases the size of the SVZ and the numbe
one representative antero-posterior level of the SVZ computed by c
3 days post-injury, demonstrating both the low variation in injury si
(yellow–red = injury overlap from 12 to 1 mouse, respectively). (B)
at 3 different time points after injury. (C) Total numbers of actively
relative to naïve at all time-points after injury (n = 5/group, P b
(E) (scale bar D: 100 μm, E: 20 μm). (F) By 3 days post-injury, SVZ
P b 0.05). The observed proliferative effect of injury was not due t
immunostaining for CldU (green) and microglia marker, Iba1 (blue)
of dividing cells that were microglia (I) was less than 8% in both naïv
H: 10 μm).Mash1+ but not EGFR+ transit-amplifying cells
contribute significantly to injury-induced
SVZ proliferation
Although Mash1+ and EGFR+ cells are both transit amplifying
cell populations, which overlap significantly in the uninjured
SVZ (Kim et al., 2009; Pastrana et al., 2009; Ciccolini et al.,
2005), we have found that these two populations respond
very differently to TBI. Nearly all actively dividing (CldU+)r of proliferating SVZ cells. (A) Contusion injury overlap map at
o-registering thymine-stained sections from 12 injured mice at
ze within the group and the absence of direct injury to the SVZ
Schematic of the labeling paradigm used to detect dividing cells
dividing cells in the dorsolateral SVZ were significantly increased
0.05), as indicated by immunostaining for CldU (D) and inset
thickness was increased by ~25% relative to naïve (n = 3/group,
o a local inflammatory response within the SVZ as observed by
at low power (G) and at high power (H) in which the percent
e and in injured (3 days) SVZ (n = 3/group, scale bar G: 100 μm,
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Mash1+ transit amplifying cells (Figs. 2C, D), and converse-
ly N90% of Mash1+ SVZ cells were CldU+ in both naïve and
injured mice (data not shown). This shows that the actively
dividing cell population within the SVZ after injury consists
mainly of the Mash1+ transit-amplifying cells, and it is
these cells that underlie the injury-induced expansion of
the SVZ.
Among the population of actively dividing SVZ cells in
the uninjured mouse, 81% expressed EGFR (Figs. 2E, F), in
agreement with previous reports that EGFR is expressed largely
by transit amplifying cells and overlaps to some degreewith the
Mash1 population (Doetsch et al., 2002; Pastrana et al., 2009;
Kim et al., 2009; Cesetti et al., 2009). However in contrast toFigure 2 Injury alters DCX+ neuroblast proliferation and revea
(A) Immunostaining for CldU (green) and DCX (red) in the naïve and in
SVZ cells in the naïve mouse are DCX+ neuroblasts (open bar) and th
post-injury (red filled bar) and remained decreased on day 7 (dark
(red) in the dorsolateral SVZ revealed that (D) N96% of actively div
Mash1+ suggesting that, since total numbers of CldU+ cells are i
population that is stimulated by injury to divide. (E) Immunostainin
revealed that (F) 81% of actively dividing cells are EGFR+ in naïve mic
a transit-amplifying population. However, unlike Mash1+ cells that
percentage of dividing cells are EGFR+ at all time points after injury
bar = 10 μm.the Mash1+ transit amplifying cells, the percent of dividing
(CldU+) cells that were EGFR+ was significantly reduced to 64%
on day 1 post-injury and remained significantly lower than
naïve on days 3 and 7 (P b 0.05, Figs. 2E, F). This reveals that it
is the non-overlapping Mash1+/EGFR− population that was
primarily responsible for the increased proliferative response.
Because almost all of the CldU+ cells are Mash1+ and vice
versa in both injured and naïve brain, CldU can be used as a
proxy for Mash1 in these studies in order to assess the
extent of overlap between Mash1 and other cellular
markers. In doing this we can determine that prior to
injury ~81% of Mash1+ transit amplifying cells co-
expressed EGFR but this is reduced to less than 64% after
injury. Thus, the cells that continue to co-express bothls two different populations of SVZ transit-amplifying cells.
jured dorsolateral SVZ revealed that (B) 35% of actively dividing
at this percentage was significantly decreased starting at day 3
red, filled bar). (C) Immunostaining for CldU (green) and Mash1
iding SVZ cells in naïve and at all time points after injury were
ncreased after injury, it is the Mash1+ transit-amplifying cell
g for CldU (green) and EGFR (red) in the naïve and injured SVZ
e SVZ (open bar) confirming that the majority of EGFR+ cells are
are stimulated to divide following injury, a significantly smaller
(filled bars). All experiments, n = 3/group, P b 0.05, each scale
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EGFR+ cells that no longer co-express Mash1 are quiescent
(see Supplemental Table 1).Brain injury increases the total number of GFAP+
SVZ cells, but not through increased proliferation
In published experiments, ablation of the fast dividing progeni-
tor cells using an anti-mitotic drug stimulates proliferation of
the previously quiescent GFAP+ stem cell population, resulting
in the repopulation of the entire SVZ niche following drug
removal (Doetsch et al., 1999b, 2002). This understanding of
lineage progression suggests that increases in highly prolifer-
ative Mash1+ cells that we observe after injury would result
from increases in the number of dividing GFAP+ stem cells
from which the transit amplifying cell populations arise.
Therefore, we tested this by examining the population of
actively dividing (CldU+) cells that were GFAP+ following
injury. However, unlike the ablation models, we found the SVZ
GFAP+ population were not stimulated to divide more and, in
fact, initially decreased proliferation at day 1 post-injury (Figs.
3A, B).
In apparent contradiction to this finding of no significant
change in proliferation by the GFAP+ cells in the SVZ, we
observed that the total number of SVZ GFAP+ cells was
significantly increased by day 3 after injury. Beginning on
day 3 post-injury the total number of GFAP+ cells was
increased by 36% relative to naïve, and remained at this
elevated level on day 7 (P b 0.05, Fig. 3C). Thus, because
there was no significant change in the very small percentage
of GFAP+ cells that were actively dividing (and no
significant difference in total numbers of GFAP+/CldU+,
Supplemental Table 1) over this 3-day period post-injury
(Fig. 3D), this suggests the expansion of the pool of GFAP+
cells after injury occurred without proliferation of GFAP+
cells.
To confirm that the GFAP+ SVZ population was increas-
ing without proliferation after injury, we used label-
retention of the thymidine analog IdU to directly determine
the relative quiescence of the GFAP+ population after
injury. In this labeling paradigm IdU was given daily for
3 weeks in order to label even the very slow-dividing,
relatively quiescent GFAP+ cell population in the SVZ
before injury. This was followed by a 10-day washout
period during which time any cells that divide would dilute
the IdU label with each division (Fig. 3E). Label intensity
measurements were then used to identify label-retaining
cells (LRCs), which reflect cells that have not undergone
division over the 10-day washout period in the injured and
naïve SVZ (Fig. 3F). We confirmed that the highest intensity
LRCs after the 10-day washout were indeed not dividing in
both the injured and naïve SVZ by looking for any double-
labeling with a second thymidine analog, CldU, given on the
day of perfusion/fixation (Fig. 3G). Thus, our quantification of
GFAP+ LRCs demonstrated that there was a significant
increase in the number of non-dividing GFAP+ cells in the
SVZ after injury (Fig. 3H), which is in agreement with our
previous data which also indicate that there is a non-
proliferative increase in the total number of GFAP+ stem
cells by day 3 after injury (Figs. 3C–D).Mash1+ transit-amplifying cells do not re-acquire
GFAP expression in response to injury
There is evidence that SVZ cell lineage progression is not
necessarily unidirectional and can be affected by specific
extracellular cues (Doetsch et al., 2002). Therefore, in order
to test the possibility that the non-proliferative increase in
the SVZ GFAP+ cell population that we observed after injury
could result from a proliferating progenitor re-acquiring
GFAP expression and becoming quiescent, we administered
CldU label once every 2 h for 8 h immediately after cortical
injury. Mice were euthanized three days later and the
number of CldU+ cells that expressed GFAP was quantified
(Fig. 4A). If actively proliferating cells were capable of
reverting back to a GFAP+ phenotype, then we would detect
a significant increase in CldU+/GFAP+ cells at 3 days post-
injury/post-labeling. However, we found that the number of
SVZ cells that were CldU+/GFAP+ 3 days after labeling was
not significantly increased after injury (P N 0.05; Fig. 4B).
Therefore, injury-induced increases in total GFAP+ cells (by
~3300 cells, Fig. 3C) cannot be accounted for by the reversion
of a population of proliferating cells back to a quiescent
GFAP-expressing phenotype. This is in agreement with our
finding that the number of GFAP+ SVZ cells which divide is a
very small population that is essentially unchanged after
injury (Fig. 3D).
There is a non-proliferative rise in EGFR+/GFAP+
neural stem cell population after injury
Similar to the GFAP+ cells in the SVZ, the total number of
EGFR+ cells was significantly increased by day 7 in the
injured brains (Fig. 4C). This occurred despite the fact that
the number of actively dividing cells that were EGFR+ was
significantly lower at all post-injury time points (P b 0.05)
as shown above (Fig. 2F). Thus, both GFAP+ and EGFR+
cells increase in number without proliferation after TBI,
suggesting a change in normal lineage progression within
the SVZ.
Co-expression of EGFR and GFAP has been shown to identify
activated stem cells in the uninjured brain (Pastrana et al.,
2009). Therefore we examined whether the non-proliferative
increase in total numbers of GFAP+ cells that we measured
(Fig. 3C) was related to the increase in the number of GFAP+/
EGFR+ stem cells. We found that there was an immediate and
sustained increase in total numbers of GFAP+/EGFR+ cells
by 65% at day 1 post-injury compared to naïve, followed by
increases of 132 and 265% at 3 and 7 days after injury,
respectively (P b 0.05; Fig. 4D). This increase in the number of
double-labeled stem cells occurred despite a significant and
sustained decrease in their proliferation after injury (P b 0.05;
Fig. 4E). Furthermore, this increase in EGFR+/GFAP+ cells
accounted for nearly 80% of the increase in total GFAP+ cells
that occurred on days 3 and 7 after injury (Fig. 3C), suggesting
that EGFR+ cells play an important role in expanding the pool
of potential stem cells after injury. In this case, the injured
SVZ does not appear to follow the conventional lineage
progression model where stem cells divide to give rise to
transit amplifying progeny.
Although EGFR+/GFAP+ SVZ cells have already been
determined to represent a stem cell population in the uninjured
55SVZ Response to Brain Injurybrain (Pastrana et al., 2009), we sought to confirm that the
non-proliferative increase in GFAP+/EGFR+ cells also reflects
an increase in the number of bona fide stem cells withinFigure 3 The total numbers of GFAP+ cells increase without prolife
red/blue, scale bar = 10 μm) revealed that (B) actively dividing cells
open bar) and this did not change with cortical injury (closed bars). (
astrocytes and therefore the pool of potential stem cells was incr
proliferation of GFAP+ cells themselves as (D), there was no signific
after injury. (E) A paradigm of IdU labeling of all cells before injury fo
brightest label-retaining cells compared to no-washout. (G) Additio
high-intensity, label-retaining IdU+ cells were indeed non-proliferat
with GFAP demonstrated that this quiescent population of high-
experiments, n = 3/group, P b 0.05, each scale bar = 10 μm.the injured SVZ. To do this we used in vitro serial clonal
neurosphere formation to establish that the injured SVZ
contained a larger number of self-renewing multipotent stemration. (A) Immunostaining for CldU, EGFR and GFAP-TK (green/
were rarely GFAP+ SVZ astrocytes under naïve conditions (12%,
C) Starting at 3 days post-injury, the total number of GFAP+ SVZ
eased. This ~3300 cell increase in GFAP+ cells was not due to
ant change in GFAP+ cells that were actively dividing in the SVZ
llowed by a washout period (F) allowed the identification of the
nal labeling with CldU prior to perfusion confirmed that these
ive 3 days after injury and similar to naïve. (H) Double-labeling
intensity IdU+/GFAP+ cells increased 3 days post-injury. All
56 G.M. Thomsen et al.cells via the functional assay. Because there is an increase in
the total number of EGFR+ cells in the SVZ after injury and
there is evidence that EGFR+ progenitors can have similar
self-renewal and multipotent properties as neural stem cells
(Doetsch et al., 2002), we first normalized the number of
EGFR+ cells from naïve and injured mice by FluorescenceFigure 4 SVZ stem cells increase in number after brain injury
amplifying population. (A) Schematic of labeling paradigm to determ
with the Mash1+ population can contribute to the increased GFAP+
CldU+/GFAP+ cells could not account for the significantly larger, 33
Fig. 3C. (C) Although the total numbers of EGFR+ SVZ cells were decr
also occurred without increased proliferation in the EGFR+ populat
stem cells significantly increased at all time points after injury.
proliferating post-injury was significantly decreased at all time point
vitro serial clonal neurosphere assays confirm that the EGFR+ SVZ cel
at all clonal passages (neurosphere number; P b 0.01) but no significa
the stimulation of growth factor or in the percentage of multipoten
dividing was significantly lower at all time points after injury while
increased at all time points, further suggesting an altered SVZ li
P b 0.05.Activated Cell (FAC) sorting and then plated the cells at clonal
density for three consecutive clonal passages. The cells from
the injured mice consistently demonstrated a greater self-
renewal capacity, and maintained multipotent differentiation
potential in keeping with the properties of increased EGFR+/
GFAP+ stem cell numbers, despite there being no evidence forwithout proliferation and they are not derived from a transit
ine if the rapidly dividing cell population, which is synonymous
population. (B) The small, non-significant increase (250 cells) in
00 total GFAP+ cell increase accumulated by day 3 post-injury in
eased initially, they were significantly increased by day 7, which
ion in Fig. 2F. (D) The number of co-labeled EGFR+/GFAP+ SVZ
(E) However, the number of these cells that were actively
s, suggesting a non-proliferative increase in their number. (F) In
ls from the injured brain had significantly increased self-renewal
nt increases in overall cell proliferation (sphere diameter) under
t clonal spheres. (G) The percentage of EGFR+ cells that were
(H) the percentage of EGFR+ cells that co-labeled for GFAP was
neage progression after injury. All experiments, n = 3/group,
57SVZ Response to Brain Injuryan increase in their proliferation in vivo after injury (Fig. 4F).
Furthermore, these functional data also demonstrate that
increased EGFR+/GFAP+ cells are not representative of
infiltrative gliosis in the SVZ.
Increased stem cell numbers are consistent with an
altered SVZ cell lineage progression after injury
SVZ transit-amplifying cells have been shown to be capable
of reverting back to a more immature progenitor cell
phenotype under special circumstances (Doetsch et al.,
2002). Our in vivo data suggests that the effect of injury
might be to slow, prevent or even to reverse the normal
lineage progression of GFAP+/EGFR+ stem cells to actively
dividing EGFR+/CldU+ transit-amplifying cells. Although we
found an increase in the total numbers of EGFR+ cells by day
7 after injury (Fig. 4C), the percentage that were actively
dividing (EGFR+/CldU+) was significantly reduced (Fig. 4G).
Despite fewer EGFR+ cells undergoing division after injury,
more EGFR+ cells co-expressed GFAP, increasing significant-
ly from ~15% in naïve SVZ to 32% by 7 days after injury
(P b 0.05; Fig. 4H). This indicates that the injury-induced
increase in the SVZ stem cell (GFAP+/EGFR+) population
does not promote the normal progression of these cells into
actively dividing (EGFR+/GFAP−) transit-amplifying cells.
We next tested the hypothesis that the EGFR+ transit
amplifying cells from the injured brain have the competence
to revert back into a stem cell state by re-acquiring GFAP
expression in agreement with others (Doetsch et al., 2002). To
do this we first FAC-sorted EGFR+ cells from the injured
(3 days) SVZ, divided the samples in half, and then incubated
them with either epidermal growth factor-supplemented
media or non-growth factor supplemented media for 4 h,
which is significantly shorter than typical in vitro cell cycle
times of 12–24 h. After the short incubation with growth
factor we determined by flow-cytometry acquisition that the
number of EGFR+/GFAP+ cells had increased compared to the
same cells that were not exposed to EGF (P = 0.04; Figs. 5A,
B). However, the same EGF exposure did not change the
number of double-labeled cells from the uninjured SVZ
(Fig. 5C), which would suggest that injury-induced signals in
vivo prime some EGFR+ cells to up-regulate GFAP expression
but not proliferation in response to receptor activation. Thus,
EGF receptor activation in vivo after injury may underlie the
non-proliferative, de-differentiation expansion of the SVZ
stem cell population (Fig. 5D).
Discussion
Post-injury hippocampal neurogenesis has been demonstrated
to have positive effects on functional recovery (Kernie and
Parent, 2010; Tsai et al., 2013). However, the neurogenic
progenitors are not known to migrate outside of the hippocam-
pus itself to effect repair elsewhere in the brain. SVZ-derived
progenitors, on the other hand, have been shown to migrate
to distal sites of injury throughout the brain where they
contribute new neurons for many months following injury. The
long-term survival and functional recovery provided by these
cells however, is quite limited (Parent et al., 2002; Parent,
2003; Ramaswamy et al., 2005; Blizzard et al., 2011; Ohab et
al., 2006; Gregorian et al., 2009; Kreuzberg et al., 2010; Jin etal., 2001). Therefore, given the encouraging example of
neurogenic recovery of function in the hippocampus, it is
hoped that therapeutic approaches aimed at specific SVZ cell
populations or within critical time periods post-injury may be
used to enhance repair throughout the brain.
Although we know that post-injury cortical neurogenesis
primarily originates from the SVZ, the early response of
specific cell phenotypes within the SVZ and the cell types
that are directly responsible for the injury-induced expan-
sion of SVZ is not well understood. A subpopulation of GFAP+
cells in the adult mammalian SVZ has been identified as
endogenous neural stem cells, and is thought to be relatively
quiescent under normal conditions (Doetsch et al., 1999a;
Garcia et al., 2004; Imura et al., 2003). GFAP+ stem cells (type
B cells) are thought to generate rapidly dividing EGFR+,
Mash1+, and Dlx2+ transit amplifying progenitors (type C
cells) which in turn give rise to CD24+ and DCX+ neuroblasts
(type A cells) which migrate to the olfactory bulb in the
uninjured brain (Doetsch et al., 1999b, 2002). This knowledge,
based partly on ablation experiments that used the anti-
mitotic agent, Ara-C, to eliminate the faster dividing progen-
itors in the SVZ showed that a slowly-dividing population of cells
was able to repopulate all of the different cell types in the SVZ,
and to rescue endogenous neurogenesis (Doetsch et al., 1999a).
From this work it has been extrapolated that a similar paradigm
occurs in response to brain injury, where the normally quiescent
stem cells are stimulated to divide, resulting in the increases in
fast-dividing transit amplifying cells and neuroblast production.
However, contrary to this conventional wisdom, we have shown
that although the neural stem cell population does expand in
response to traumatic brain injury, this does not result from
more proliferation after injury.
We find that the Mash1-expressing transit-amplifying cells
are the primary cell type directly responsible for injury-
induced increases in SVZ size and cell proliferation. No other
cell type examined, including GFAP+, EGFR+ or DCX+ cells
increased division in response to injury. In fact, the EGFR+
cells, which under normal conditions have been shown to also
be largely a transit-amplifying population (Doetsch et al.,
2002), divide less after injury. Although both EGFR+ and
Mash1+ SVZ cells are both transit amplifying progenitor
populations, we observed that even in naïve brains the
EGFR+ cells were less proliferative than the Mash1+ cells
(98% of Mash1+ cells actively proliferate versus 46% of EGFR+
ells) and are even less proliferative after injury. Thus, there is
a non-overlapping, EGFR+/Mash1− population that is revealed
by injury to be a non-transit amplifying progenitor population
within the SVZ that has a divergent response to TBI from the
Mash1+ population. Since the Mash1+ cells are the primary
proliferative population in the SVZ both before and after
injury, they clearly would not directly contribute to the
non-proliferative increases we observed in EGFR+/GFAP+
stem cells. Our data suggest that it is the quiescent EGFR+/
Mash1− population, which reverts to a stem cell state and
up-regulates GFAP expression in response to injury-induced
signaling. Consequently, it is the decreased proliferation of
the EGFR+/Mash1− population and altered lineage progres-
sion, which underlies the increase in label-retaining SVZ stem
cells between naïve and injured brain.
Unlike ablation models which suggest that SVZ cell lineage
progression involves an activation of stem cell proliferation
that give rise to highly proliferative progenitors, brain
58 G.M. Thomsen et al.injury results in an increase in GFAP+ stem cells and EGFR+
progenitors without any corresponding increase in their
proliferation. In vitro serial clonal density assays performed
with EGFR+ cells isolated from the SVZ confirmed that the
non-proliferative increase in EGFR+/GFAP+ cell number that
we observed does indeed correspond to an increase in a
self-renewing, multipotent stem cell population within the
SVZ of the injured brain. Although it has been shown that
EGF-responsive SVZ transit amplifying cells can also have
multipotent, self-renewing capacities indistinguishable from
neural stem cells in the presence of growth factor (Doetsch et
al., 2002), we observed that injury-induced increases in
self-renewal are still reflected in vitro when the number ofFigure 5 Increased stem cell numbers from the non-proliferative p
the EGFR+ transit amplifying cells. (A) Following injury, in vitro e
number of EGFR+ cells that co-expressed GFAP (relative to no-EGF
SVZ of the injured brain to re-acquire GFAP expression. (B) Scatter p
did not re-acquire GFAP expression, indicating that some injury-ind
stimulation. (D) Representation of a change in lineage progression
CldU− cells (gray circle/no border) becomes GFAP+ (gray astro
transit-amplifying cells (gray circle/black border). All experiments,EGFR+ cells have been normalized from the injured and naïve
brains. Even though the number of Mash1+ transit amplifying
cells was also increased in the SVZ after injury, Mash1+ cells
were shown to not make any contribution to self-renewal in
functional clonal neurosphere assays (Parras et al., 2004).
Thus, despite equal exposure to growth factor and equal
numbers of EGFR+ SVZ cells being plated in our clonal assays,
the increased capacity for self-renewal could be detected in
cells from the SVZ of the injured brain, indicating an increase
in neural stem cell number in agreement with our in vivo
observations.
The increase in neural stem cells without proliferation
after injury supports the idea that SVZ lineage progressionopulation after injury may result from a reversion/conversion of
xposure to EGF for 4 h resulted in a significant increase in the
exposure), demonstrating the competence of the cells from the
lots of FACS acquisition for GFAP. (C) SVZ cells from naïve mice
uced signaling must influence cellular response to growth factor
after injury whereby a population of non-proliferative EGFR+/
cyte/black border) at the expense of becoming proliferative
n = 3/group, P b 0.05.
59SVZ Response to Brain Injuryis not necessarily unidirectional. For example, increased
exposure to EGF in the SVZ of uninjured mice has been
shown to induce a reversion of the EGFR+ transit amplifying
progenitor population back to a stem cell state (Doetsch et
al., 2002). In agreement with this explanation, our data
show that a purified population of EGFR+ cells isolated by
FACS from the SVZ of injured animals are capable of “turning
on” GFAP expression consistent with a reversion to an
EGFR+/GFAP+ activated stem cell state following a brief
exposure to EGF whereas the same cells from the uninjured
brain were not competent to do this. Therefore, these
findings show that the increase in the number of EGFR+/
GFAP+ stem cells can be derived from an EGFR+ transit
amplifying population and suggests that injury-induced signals
may alter the direction of normal cell lineage relationships.
Correlative evidence supports the idea that EGFR ligands
influence the cellular response in the SVZ after injury: EGF
and TGF-α have been shown to promote the expansion of
transit-amplifying cells in the SVZ at the expense of neuroblast
production, similar to what we observed after TBI (Doetsch et
al., 2002; Kim et al., 2009; Craig et al., 1996; Ninomiya et al.,
2006; Alagappan et al., 2009). Furthermore, both EGF and
TGF-α are substantially upregulated following brain injury
(Sundholm-Peters et al., 2005; Helmy et al., 2010).
Finally, although we show that the increase in SVZ stem
cells does not occur via proliferation in vivo post-injury, this
does not rule out the possibility that they leave this quiescent
state at times after the 7 day time point of the current data.
After stroke, new neurons migrate from the SVZ to the site
of injury for up to 4 months following injury, indicating a
sustained increase in neurogenesis (Thored et al., 2006; Leker
et al., 2007). This long-term supply of neuroblasts would likely
require stem cell proliferation to replenish and maintain the
fast dividing progenitor pool from which the neuroblasts are
derived in the SVZ. It is therefore conceivable that this acute
7-day period, which we have studied, represents a “priming”
or activating period for the stem cell pool during which time
the number of stem cells increases without proliferation.
Maintaining the balance between the different populations of
stem and progenitor cells within the SVZ niche may be critical
for promoting and manipulating neurogenesis under both
normal and injured conditions.
Few studies have closely examined the specific cell
populationswithin the SVZ that respond to injury after different
insults. Therefore, it is uncertain if our findings are unique to
traumatic brain injury or if there is a comparable response
in the SVZ after other types of injuries. Certainly, we have
established that the TBI response in the intact SVZ is
significantly altered from the response after ablation of
different cell populations in the SVZ. Thus, detailed knowledge
of the diverse cellular response to brain injuries would
significantly aid in the development of appropriate therapeu-
tic approaches aimed at specific cell populations, signaling
pathways, or within specific time periods post-injury in order
to enhance endogenous neurogenesis and brain repair.
Acknowledgments
We wish to thank Dr. David McArthur for helpful discussion about the
statistics. This work was supported by the UCLA Brain Injury Research
Center, and Award Number R01 NS055910 and NRSA 5F31NS064697-02
from the National Institute of Neurological Disorders and Stroke (NINDS).Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.04.013.References
Alagappan, D., Lazzarino, D. a, Felling, R.J., et al., 2009. Brain
injury expands the numbers of neural stem cells and progenitors
in the SVZ by enhancing their responsiveness to EGF. ASN Neurol.
1 (2), 95–111.
Arvidsson, A., Collin, T., Kirik, D., et al., 2002. Neuronal replacement
from endogenous precursors in the adult brain after stroke. Nat.
Med. 8 (9), 963–970.
Blizzard, C.A., Chuckowree, J.A., King, A.E., et al., 2011. Focal
damage to the adult rat neocortex induces wound healing
accompanied by axonal sprouting and dendritic structural
plasticity. Cereb. Cortex 21 (2), 281–291.
Brown, J.P., Couillard-Després, S., Cooper-Kuhn, C.M., et al., 2003.
Transient expression of doublecortin during adult neurogenesis.
J. Comp. Neurol. 10 (1), 1–10.
Bush, T.G., Savidge, T.C., Freeman, T.C., et al., 1998. Fulminant
jejuno-ileitis following ablation of enteric glia in adult trans-
genic mice. Cell 93, 189–201.
Cesetti, T., Obernier, K., Bengtson, C.P., et al., 2009. Analysis of
stem cell lineage progression in the neonatal subventricular zone
identifies EGFR+/NG2− cells as transit-amplifying precursors.
Stem Cells 27 (6), 1443–1454.
Chen, X.-H., Iwata, A., Nonaka, M., et al., 2003. Neurogenesis and glial
proliferation persist for at least one year in the subventricular zone
following brain trauma in rats. J. Neurotrauma 20 (7), 623–631.
Ciccolini, F., Mandl, C., Hölzl-Wenig, G., et al., 2005. Prospective
isolation of late development multipotent precursors whose
migration is promoted by EGFR. Dev. Biol. 284 (1), 112–125.
Craig, G., Der Kooyl, V., Reynolds, A., et al., 1996. In vivo growth
factor expansion neural precursor cell populations. J. Neurosci.
16 (8), 2649–2658.
Doetsch, F., Caille, I., Lim, D.A., et al., 1999a. Subventricular zone
astrocytes are neural stem cells in the adult mammalian brain.
Cell 97, 703–716.
Doetsch, F., García-Verdugo, J.M., Alvarez-Buylla, A., 1999b. Regen-
eration of a germinal layer in the adult mammalian brain. Proc.
Natl. Acad. Sci. U. S. A. 96 (20), 11619–11624.
Doetsch, F., Petreanu, L., Caille, I., et al., 2002. EGF converts
transit-amplifying neurogenic precursors in the adult brain into
multipotent stem cells. Neuron 36, 1021–1034.
Garcia, a D.R., Doan, N.B., Imura, T., et al., 2004. GFAP-expressing
progenitors are the principal source of constitutive neurogenesis
in adult mouse forebrain. Nat. Neurosci. 7 (11), 1233–1241.
Gregorian, C., Nakashima, J., Le Belle, J., et al., 2009. Deletion in adult
neural stem/progenitor cells enhances constitutive neurogenesis.
Stem Cells 29 (6), 1874–1886.
Gould, E., Tanapat, P., 1997. Lesion-induced proliferation of neuronal
progenitors in the dentate gyrus of the adult rat. Neuroscience 80
(2), 427–436.
Helmy, A., Carpenter, K.L.H., Menon, D.K., et al., 2010. The
cytokine response to human traumatic brain injury: temporal
profiles and evidence for cerebral parenchymal production. J.
Cereb. Blood Flow Metab. 31 (2), 658–670.
Imura, T., Kornblum, H.I., Sofroniew, M.V., 2003. The predominant
neural stem cell isolated from postnatal and adult forebrain but
not early embryonic forebrain expresses GFAP. Stem Cells 23 (7),
2824–2832.
Jenkinson, M., Smith, S., 2001. A global optimisation method for
robust affine registration of brain images. Med. Image Anal. 5
(2), 143–156.
60 G.M. Thomsen et al.Jin, K., Minami, M., Lan, J.Q., et al., 2001. Neurogenesis in dentate
subgranular zone and rostral subventricular zone after focal
cerebral ischemia in the rat. Proc. Natl. Acad. Sci. U. S. A. 98
(8), 4710–4715.
Kernie, S.G., Parent, J.M., 2010. Forebrain neurogenesis after focal
ischemic and traumatic brain injury. Neurobiol. Dis. 37 (2),
267–274.
Kim, Y., Comte, I., Szabo, G., et al., 2009. Adult mouse subventricular
zone stem and progenitor cells are sessile and epidermal growth
factor receptor negatively regulates neuroblast migration. PLoS
ONE 4 (12), e8122.
Kreuzberg, M., Kanov, E., Timofeev, O., et al., 2010. Increased
subventricular zone-derived cortical neurogenesis after ischemic
lesion. Exp. Neurol. 226 (1), 90–99.
Le Belle, J.E., Orozco, N.M., Paucar, A.A., et al., 2011. Proliferative
neural stem cells have high endogenous ROS levels that regulate
self-renewal and neurogenesis in a PI3K/Akt-dependant manner.
Cell Stem Cell 8 (1), 59–71.
Leker, R.R., Soldner, F., Velasco, I., et al., 2007. Long lasting
regeneration after ischemia in the cerebral cortex. Stroke 38
(1), 153.
Magavi, S.S., Leavitt, B.R., Macklis, J.D., 2000. Induction of
neurogenesis in the neocortex of adult mice. Nature 405
(6789), 951–955.
Morshead, C.M., Reynolds, B.A., Craig, C.G., et al., 1994. Neural
stem cells in the adult mammalian forebrain: a relatively
quiescent subpopulation of subependymal cells. Neuron 13,
1071–1082.
Myer, D.J., Gurkoff, G.G., Lee, S.M., et al., 2006. Essential
protective roles of reactive astrocytes in traumatic brain injury.
Brain 2761–2772.
Ninomiya, M., Yamashita, T., Araki, N., et al., 2006. Enhanced
neurogenesis in the ischemic striatum following EGF-induced
expansion of transit-amplifying cells in the subventricular zone.
Neurosci. Lett. 403 (1–2), 63–67.
Ohab, J.J., Fleming, S., Blesch, A., et al., 2006. A neurovascular niche
for neurogenesis after stroke. J. Neurosci. 26, 13007–130016.Parent, J.M., Vexler, Z.S., Gong, C., et al., 2002. Rat forebrain
neurogenesis and striatal neuron replacement after focal stroke.
Ann. Neurol. 52 (6), 802–813.
Parent, J.M., 2003. Injury-induced neurogenesis in the adult
mammalian brain. Neuroscientist 9 (4), 261–272.
Parras, C.M., Galli, R., Britz, O., et al., 2004. Mash1 specifies neurons and
oligodendrocytes in the postnatal brain. Embo J. 23 (22), 4495–4505.
Pastrana, E., Cheng, L.-C., Doetsch, F., 2009. Simultaneous prospective
purification of adult subventricular zone neural stem cells and their
progeny. Proc. Natl. Acad. Sci. U. S. A. 106 (15), 6387–6392.
R Development Core Team, 2008. R: a Language and Environment for
Statistical Computing. R. Foundation for Statistical Computing,
Vienna, Austria (ISBN 3-900051-07-0).
Ramaswamy, S., Goings, G., Soderstrom, K., 2005. Cellular prolifer-
ation and migration following a controlled cortical impact in the
mouse. Brain Res. 1053, 38–53.
Rasband, W.S., 2008. ImageJ. U. S. National Institutes of Health,
Bethesda, Maryland, USA http://imagej.nih.gov/ij/, 1997-2014.
Sundholm-Peters, N.L., Yang, H.K.C., Goings, G.E., et al., 2005.
Subventricular zone neuroblasts emigrate toward cortical lesions.
J. Neuropathol. Exp. Neurol. 64 (12), 1089–1100.
Thored, P., Arvidsson, A., Cacci, E., et al., 2006. Persistent production
of neurons from adult brain stem cells during recovery after stroke.
Stem Cells 24 (3), 739–747.
Tonchev, A., Yamashima, T., Zhao, L., et al., 2003. Proliferation of
neural and neuronal progenitors after global brain ischemia in
young adult macaque monkeys. Mol. Cell. Biol. 23 (2), 292–301.
Tsai, Y.-W., Yang, Y.-R., Sun, S.H., et al., 2013. Post ischemia
intermittent hypoxia induces hippocampal neurogenesis and
synaptic alterations and alleviates long-term memory impair-
ment. J. Cereb. Blood Flow Metab. 33 (5), 764–773.
Yagita, Y., Kitagawa, K., Ohtsuki, T., et al., 2001. Neurogenesis by
progenitor cells in the ischemic adult rat hippocampus. Stroke 32
(8), 1890–1896.
Yamamoto, S., Yamamoto, N., Kitamura, T., et al., 2001. Proliferation
of parenchymal neural progenitors in response to injury in the
adult rat spinal cord. Exp. Neurol. 172 (1), 115–127.
